Producer

Shandong Weigao Blood Purification Products

Weihai, Shandong-based subsidiary of Weigao Group (China's largest medical device company) producing dialyzers and bloodlines. Held 32.4% of China's dialyzer market and 32.6% of China's bloodline market in 2021. China has the world's largest dialysis patient population, making Weigao's concentration position globally significant.

Inputs supplied

Goods downstream

Facilities

Stories

Where they make it

1 facility

Weigao Blood Purification Weihai HQ & Production →

manufacturing

Primary production site for Weigao dialyzers and bloodlines. Weihai, Shandong Province. As China's dialysis patient population is the world's largest, disruption at this facility would have global significance.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

← Browse all goods